Related Experiment Video
Updated: Sep 23, 2025
Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay
Published on: August 14, 2018
Highly sensitive and specific screening of EGFR mutation using a PNA microarray-based fluorometric assay based on
Xiaojun Xu1,2, Shu Xing1, Mengjia Xu1,3
1Cixi Institute of Biomedical Engineering, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences Ningbo 315201 P. R. China zhaochao@nimte.ac.cn.
This study presents a novel peptide nucleic acid microarray method for detecting epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC). The technique offers sensitive, specific, and high-throughput analysis, aiding in NSCLC diagnosis and treatment.
Area of Science:
- Biotechnology
- Molecular Diagnostics
- Cancer Research
Background:
- Epidermal growth factor receptor (EGFR) mutations are crucial biomarkers for non-small cell lung cancer (NSCLC) diagnosis and targeted therapy.
- Accurate and sensitive detection of EGFR mutations, particularly deletions, is essential for effective patient management.
- Existing methods for EGFR mutation screening can be costly and require specialized equipment, limiting their accessibility.
Purpose of the Study:
- To develop a facile, sensitive, and specific peptide nucleic acid (PNA) microarray-based fluorometric method for detecting EGFR mutations.
- To enable high-throughput analysis of EGFR mutations, especially in resource-limited settings.
- To provide a novel diagnostic approach for gene deletion mutations in other diseases.
Main Methods:
- Utilized a PNA microarray for efficient capture of EGFR gene sequences on a 96-well plate.
- Employed rolling circle amplification (RCA) with a padlock probe to specifically amplify EGFR mutation sequences.
- Integrated graphene oxide (GO) and a fluorescently-labeled detection probe (F-DP) for sensitive detection of RCA products.
Main Results:
- Achieved a detection limit of 0.3 pM for EGFR mutations.
- Demonstrated high discrimination capability between EGFR mutation and wildtype sequences.
- The PNA microarray and fluorescence quenching platform facilitate high-throughput analysis without complex equipment.
Conclusions:
- The developed PNA microarray-based fluorometric method offers a sensitive, specific, and cost-effective approach for EGFR mutation detection in NSCLC.
- This system is suitable for high-throughput screening in resource-limited environments.
- The detection strategy holds potential for diagnosing other genetic deletion-related diseases.
